We are live on
!
Find out more
SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
37 hedge funds and large institutions have $51.5M invested in Sorrento Therapeutics, Inc. in 2014 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
133% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 6
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
23% more funds holding
Funds holding: 30 → 37 (+7)
8% less capital invested
Capital invested by funds: $55.9M → $51.5M (-$4.3M)
Holders
37
Holders Change
+7
Holders Change %
+23.33%
% of All Funds
1.06%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
16
Increased
14
Reduced
6
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
Aisling Capital
New York
|
+$8.62M |
| 2 |
TC
Talkot Capital
Sausalito,
California
|
+$5.25M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$2.26M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.51M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$1.49M |
Top Sellers
| 1 |
Neuberger Berman Group
New York
|
-$566K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$396K |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
-$387K |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$385K |
| 5 |
Jane Street
New York
|
-$357K |
